Eve Energy's Subsidiary Receives over HK$95 Million Cash Dividend from Smoore International

Business by 2FIRSTS.ai

Jun.20.2024

Eve Energy's Subsidiary Receives over HK$95 Million Cash Dividend from Smoore International

Eve Energy's subsidiary receives over HK$95 million in cash dividend from Smoore International, with no impact on 2024 profit.

Eve Energy announced on the evening of June 19th that its wholly-owned subsidiary, EBIL, holds 1.902 billion shares of Smoore International. As of the announcement date, EBIL has received a cash dividend of HK$95.076 million from Smoore International.

The company accounts for its long-term equity investment in Smoore International using the equity method, and the dividends received will have no impact on the net profit of the company for the 2024 consolidated financial statements.

References:

[1] 亿纬锂能：孙公司收到参股公司思摩尔国际现金分红

Also Read:

[1] Eve Lithium Energy: Gel Technology Has Battery Products Applied in E-cigarette Field

[2] Strategic Partnership Agreement Signed between Yiwei Lithium and Yan Yang Technology

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Russia’s State Duma May Soon Consider Full Ban on Vape Sales

Russia’s State Duma will soon consider a proposal to impose a complete ban on the sale of vapes. The move follows President Vladimir Putin’s endorsement of a nationwide prohibition. Lawmaker Aleksey Volotskov said vape use has surged by 52% since early 2025, with illegal products now dominating 80% of the market.

Nov.11 by 2FIRSTS.ai

CNIPA Targets E-Cigarettes as Key Focus in Crackdown on Trademark Violations

National Intellectual Property Office issued a notice to strengthen management of illegal use of trademarks, promoting fair competition.

Nov.25 by 2FIRSTS.ai

JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up

Japan Tobacco (JT) delivered a strong Q3 2025. Revenue rose 18.3% year over year to ¥947.2 billion, with adjusted operating profit up 27.8% to ¥279.0 billion (+20.8% at constant currency) and net profit up 29.7% to ¥176.7 billion. Growth was led by reduced-risk products (RRP): total RRP volume climbed 40%, with heated tobacco (HTS) up 53%. In Japan, the launches of Ploom AURA and EVO pods pushed HTS category share to 15.5%, while the Ploom user base has nearly doubled versus two years ago.

Oct.30 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.